Founded in 2015 by Nuray George Ugras, Cytegen is focused on the restoration of critical biological function through the promotion of mitochondrial fitness. CyteGen’s hypothesis is that exercise induces the secretion of blood-borne proteins that act systemically to stimulate removal of damaged mitochondria and enrichment of healthy mitochondria mitochondrial fitness,” the application says. “The company’s goal is to identify these proteins to develop into biologics that would serve as a platform to treat the myriad of diseases associated with mitochondrial dysfunction.